Cannabinoid signaling in the skin

Therapeutic potential of the "c(ut)annabinoid" system

Kinga Fanni Tóth, Dorottya Ádám, T. Bíró, Attila Oláh

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The endocannabinoid system (ECS) has lately been proven to be an important, multifaceted homeostatic regulator, which influences a wide-variety of physiological processes all over the body. Its members, the endocannabinoids (eCBs; e.g., anandamide), the eCB-responsive receptors (e.g., CB1, CB2), as well as the complex enzyme and transporter apparatus involved in the metabolism of the ligands were shown to be expressed in several tissues, including the skin. Although the best studied functions over the ECS are related to the central nervous system and to immune processes, experimental efforts over the last two decades have unambiguously confirmed that cutaneous cannabinoid ("c[ut]annabinoid") signaling is deeply involved in the maintenance of skin homeostasis, barrier formation and regeneration, and its dysregulation was implicated to contribute to several highly prevalent diseases and disorders, e.g., atopic dermatitis, psoriasis, scleroderma, acne, hair growth and pigmentation disorders, keratin diseases, various tumors, and itch. The current review aims to give an overview of the available skin-relevant endo- and phytocannabinoid literature with a special emphasis on the putative translational potential, and to highlight promising future research directions as well as existing challenges.

Original languageEnglish
Article number24050918
JournalMolecules
Volume24
Issue number5
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Endocannabinoids
Cannabinoids
Skin
dermatitis
disorders
keratins
homeostasis
transporter
central nervous system
regulators
hair
metabolism
regeneration
maintenance
enzymes
tumors
Pigmentation Disorders
Neurology
Growth Disorders
Physiological Phenomena

Keywords

  • acne
  • atopic dermatitis
  • cannabinoid
  • fibrosis
  • hair growth
  • inflammation
  • itch
  • psoriasis
  • skin
  • tumor
  • wound healing

ASJC Scopus subject areas

  • Analytical Chemistry
  • Chemistry (miscellaneous)
  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery
  • Physical and Theoretical Chemistry
  • Organic Chemistry

Cite this

Cannabinoid signaling in the skin : Therapeutic potential of the "c(ut)annabinoid" system. / Tóth, Kinga Fanni; Ádám, Dorottya; Bíró, T.; Oláh, Attila.

In: Molecules, Vol. 24, No. 5, 24050918, 01.01.2019.

Research output: Contribution to journalReview article

Tóth, Kinga Fanni ; Ádám, Dorottya ; Bíró, T. ; Oláh, Attila. / Cannabinoid signaling in the skin : Therapeutic potential of the "c(ut)annabinoid" system. In: Molecules. 2019 ; Vol. 24, No. 5.
@article{2ac64580e82f448d9d4f859391652dd1,
title = "Cannabinoid signaling in the skin: Therapeutic potential of the {"}c(ut)annabinoid{"} system",
abstract = "The endocannabinoid system (ECS) has lately been proven to be an important, multifaceted homeostatic regulator, which influences a wide-variety of physiological processes all over the body. Its members, the endocannabinoids (eCBs; e.g., anandamide), the eCB-responsive receptors (e.g., CB1, CB2), as well as the complex enzyme and transporter apparatus involved in the metabolism of the ligands were shown to be expressed in several tissues, including the skin. Although the best studied functions over the ECS are related to the central nervous system and to immune processes, experimental efforts over the last two decades have unambiguously confirmed that cutaneous cannabinoid ({"}c[ut]annabinoid{"}) signaling is deeply involved in the maintenance of skin homeostasis, barrier formation and regeneration, and its dysregulation was implicated to contribute to several highly prevalent diseases and disorders, e.g., atopic dermatitis, psoriasis, scleroderma, acne, hair growth and pigmentation disorders, keratin diseases, various tumors, and itch. The current review aims to give an overview of the available skin-relevant endo- and phytocannabinoid literature with a special emphasis on the putative translational potential, and to highlight promising future research directions as well as existing challenges.",
keywords = "acne, atopic dermatitis, cannabinoid, fibrosis, hair growth, inflammation, itch, psoriasis, skin, tumor, wound healing",
author = "T{\'o}th, {Kinga Fanni} and Dorottya {\'A}d{\'a}m and T. B{\'i}r{\'o} and Attila Ol{\'a}h",
year = "2019",
month = "1",
day = "1",
doi = "10.3390/molecules24050918",
language = "English",
volume = "24",
journal = "Molecules",
issn = "1420-3049",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "5",

}

TY - JOUR

T1 - Cannabinoid signaling in the skin

T2 - Therapeutic potential of the "c(ut)annabinoid" system

AU - Tóth, Kinga Fanni

AU - Ádám, Dorottya

AU - Bíró, T.

AU - Oláh, Attila

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The endocannabinoid system (ECS) has lately been proven to be an important, multifaceted homeostatic regulator, which influences a wide-variety of physiological processes all over the body. Its members, the endocannabinoids (eCBs; e.g., anandamide), the eCB-responsive receptors (e.g., CB1, CB2), as well as the complex enzyme and transporter apparatus involved in the metabolism of the ligands were shown to be expressed in several tissues, including the skin. Although the best studied functions over the ECS are related to the central nervous system and to immune processes, experimental efforts over the last two decades have unambiguously confirmed that cutaneous cannabinoid ("c[ut]annabinoid") signaling is deeply involved in the maintenance of skin homeostasis, barrier formation and regeneration, and its dysregulation was implicated to contribute to several highly prevalent diseases and disorders, e.g., atopic dermatitis, psoriasis, scleroderma, acne, hair growth and pigmentation disorders, keratin diseases, various tumors, and itch. The current review aims to give an overview of the available skin-relevant endo- and phytocannabinoid literature with a special emphasis on the putative translational potential, and to highlight promising future research directions as well as existing challenges.

AB - The endocannabinoid system (ECS) has lately been proven to be an important, multifaceted homeostatic regulator, which influences a wide-variety of physiological processes all over the body. Its members, the endocannabinoids (eCBs; e.g., anandamide), the eCB-responsive receptors (e.g., CB1, CB2), as well as the complex enzyme and transporter apparatus involved in the metabolism of the ligands were shown to be expressed in several tissues, including the skin. Although the best studied functions over the ECS are related to the central nervous system and to immune processes, experimental efforts over the last two decades have unambiguously confirmed that cutaneous cannabinoid ("c[ut]annabinoid") signaling is deeply involved in the maintenance of skin homeostasis, barrier formation and regeneration, and its dysregulation was implicated to contribute to several highly prevalent diseases and disorders, e.g., atopic dermatitis, psoriasis, scleroderma, acne, hair growth and pigmentation disorders, keratin diseases, various tumors, and itch. The current review aims to give an overview of the available skin-relevant endo- and phytocannabinoid literature with a special emphasis on the putative translational potential, and to highlight promising future research directions as well as existing challenges.

KW - acne

KW - atopic dermatitis

KW - cannabinoid

KW - fibrosis

KW - hair growth

KW - inflammation

KW - itch

KW - psoriasis

KW - skin

KW - tumor

KW - wound healing

UR - http://www.scopus.com/inward/record.url?scp=85062639776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062639776&partnerID=8YFLogxK

U2 - 10.3390/molecules24050918

DO - 10.3390/molecules24050918

M3 - Review article

VL - 24

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 5

M1 - 24050918

ER -